RSCM
AMYT

Rock Springs Capital Management’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Rock Springs Capital Management’s Portfolio AMYT Stock Details AMYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,325,625
Closed -$19.3M – 127
2023
Q1 		$19.3M Hold
1,325,625
– – 0.46% 57
2022
Q4 		$9.68M Hold
1,325,625
– – 0.23% 75
2022
Q3 		$9.17M Buy
1,325,625
+13,000
+1% +$97K 0.24% 82
2022
Q2 		$9.18M Buy
1,312,625
+6,800
+0.5% +$53K 0.27% 80
2022
Q1 		$10.8M Hold
1,305,825
– – 0.27% 79
2021
Q4 		$14.1M Buy
1,305,825
+10,600
+0.8% +$114K 0.33% 78
2021
Q3 		$15.6M Buy
+1,295,225
New +$14.6M 0.33% 82

Rock Springs Capital Management's AMYT Position: Q2 2023 in Review

Rock Springs Capital Management sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 1,325,625 shares — an estimated $19.3M sold.

Rock Springs Capital Management first reported a position in AMYT in Q3 2021 and held it in 7 quarters. The position peaked at $19.3M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

  • Rock Springs Capital Management reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • Rock Springs Capital Management sold 1,325,625 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $19.3M.
  • Rock Springs Capital Management first reported a position in Amryt Pharma plc American Depositary Shares in Q3 2021 and held it in 7 quarters.
  • Rock Springs Capital Management's Amryt Pharma plc American Depositary Shares position peaked at $19.3M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Rock Springs Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.